Eden Research (LON:EDEN) Shares Down 3.3% – Here’s What Happened

Posted by Defense World Staff on Feb 24th, 2025

Eden Research plc (LON:EDEN – Get Free Report) was down 3.3% during trading on Saturday . The stock traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). Approximately 450,985 shares traded hands during trading, a decline of 52% from the average daily volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Price Performance

The company has a fifty day moving average of GBX 3.87 and a 200-day moving average of GBX 3.95. The firm has a market cap of £18.56 million, a P/E ratio of -12.19 and a beta of 0.92. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42.

Insiders Place Their Bets

In other Eden Research news, insider Lykele van der Broek acquired 256,000 shares of the business’s stock in a transaction on Thursday, February 6th. The shares were acquired at an average price of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,958.74). Also, insider Alexander John Abrey acquired 540,540 shares of the business’s stock in a transaction on Tuesday, January 28th. The stock was acquired at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,362.19). Insiders own 14.02% of the company’s stock.

About Eden Research

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.